Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Pharmacological Chaperone Therapy for Pompe Disease.

Molecules (Basel, Switzerland)

Borie-Guichot M, Tran ML, Génisson Y, Ballereau S, Dehoux C.
PMID: 34885805
Molecules. 2021 Nov 29;26(23). doi: 10.3390/molecules26237223.

Pompe disease (PD), a lysosomal storage disease, is caused by mutations of the GAA gene, inducing deficiency in the acid alpha-glucosidase (GAA). This enzymatic impairment causes glycogen burden in lysosomes and triggers cell malfunctions, especially in cardiac, smooth and...

Cite
Borie-Guichot M, Tran ML, Génisson Y, et al. Pharmacological Chaperone Therapy for Pompe Disease. Molecules. 2021;26(23)doi: 10.3390/molecules26237223.
Borie-Guichot, M., Tran, M. L., Génisson, Y., Ballereau, S., & Dehoux, C. (2021). Pharmacological Chaperone Therapy for Pompe Disease. Molecules (Basel, Switzerland), 26(23), . https://doi.org/10.3390/molecules26237223
Borie-Guichot, Marc, et al. "Pharmacological Chaperone Therapy for Pompe Disease." Molecules (Basel, Switzerland) vol. 26,23 (2021). doi: https://doi.org/10.3390/molecules26237223
Borie-Guichot M, Tran ML, Génisson Y, Ballereau S, Dehoux C. Pharmacological Chaperone Therapy for Pompe Disease. Molecules. 2021 Nov 29;26(23). doi: 10.3390/molecules26237223. PMID: 34885805.
Copy Download .nbib Format: NLM
Pharmacological Chaperone Therapy for Pompe Disease.

Molecules (Basel, Switzerland)

Borie-Guichot M, Tran ML, Génisson Y, Ballereau S, Dehoux C.
PMID: 34885805
Molecules. 2021 Nov 29;26(23). doi: 10.3390/molecules26237223.

Pompe disease (PD), a lysosomal storage disease, is caused by mutations of the GAA gene, inducing deficiency in the acid alpha-glucosidase (GAA). This enzymatic impairment causes glycogen burden in lysosomes and triggers cell malfunctions, especially in cardiac, smooth and...

Cite
Borie-Guichot M, Tran ML, Génisson Y, et al. Pharmacological Chaperone Therapy for Pompe Disease. Molecules. 2021;26(23)doi: 10.3390/molecules26237223.
Borie-Guichot, M., Tran, M. L., Génisson, Y., Ballereau, S., & Dehoux, C. (2021). Pharmacological Chaperone Therapy for Pompe Disease. Molecules (Basel, Switzerland), 26(23), . https://doi.org/10.3390/molecules26237223
Borie-Guichot, Marc, et al. "Pharmacological Chaperone Therapy for Pompe Disease." Molecules (Basel, Switzerland) vol. 26,23 (2021). doi: https://doi.org/10.3390/molecules26237223
Borie-Guichot M, Tran ML, Génisson Y, Ballereau S, Dehoux C. Pharmacological Chaperone Therapy for Pompe Disease. Molecules. 2021 Nov 29;26(23). doi: 10.3390/molecules26237223. PMID: 34885805; PMCID: PMC8659197.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries